Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02463266 · ClinicalTrials.gov registry record
Evaluation of the PACE/PACENET BHL Clinical Program
A clinical trial of Depression and Anxiety, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT02463266: Recruiting study of Depression and Anxiety, sponsored by University of Pennsylvania.
NCT02463266 is a study of Depression and Anxiety that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 4,000 participants, above the 780-participant average among 679 other Depression trials with a reported enrollment target (413% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02463266, a study of Depression and Anxiety, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The SUpporting Seniors Receiving Treatment And INtervention (SUSTAIN) program is a telephone-based clinical service designed to help identify and manage behavioral health issues among PACE/PACENET enrollees. The purpose of the current project is to a) explore moderators of treatment response among beneficiaries in the SUSTAIN Clinical Program and b) to evaluate the sustained clinical effects of the program.
Primary Outcome
A measure of physical and mental health functioning
Conditions Studied
Interventions
- BEHAVIORAL SUSTAIN Monitoring and Care Management
Study Locations (1)
Pennsylvania
- Department of Psychiatry (Center for Psychotherapy Research), University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2014-03 |
| Est. Completion | 2026-12 |
What NCT02463266 shows while recruiting
NCT02463266 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 780-participant average among 679 other Depression trials with a reported enrollment target (413% higher).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which SUSTAIN Monitoring and Care Management is the first listed.
NCT02463266 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02463266 about?
NCT02463266 is a clinical study titled "Evaluation of the PACE/PACENET BHL Clinical Program". The SUpporting Seniors Receiving Treatment And INtervention (SUSTAIN) program is a telephone-based clinical service designed to help identify and manage behavioral health issues among PACE/PACENET enrollees. The purpose of the current project is to a) explore moderators of treatment response among b...
What is the current status of trial NCT02463266?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2014-03. Estimated completion is 2026-12.
What conditions does trial NCT02463266 study?
This clinical trial studies the following conditions: Depression, Anxiety, Pain, Chronic.
What interventions are being tested in trial NCT02463266?
The interventions under investigation include: SUSTAIN Monitoring and Care Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT02463266?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02463266 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02463266's enrollment target sits among peer trials
4,000 18th of 679 higher than 661 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia